Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026)
Structure Therapeutics (GPCR) recorded quarterly Tax Provisions of $190000.0 in Q1 2026, up 11.76% quarter-over-quarter from $170000.0 in Q4 2025, and up 93.88% on a YoY basis from $98000.0 in Q1 2025.
Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026) Analysis & Trends
Structure Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $190000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 93.88% year-over-year to $190000.0; the TTM figure through Mar 2026 stood at $607000.0 (up 60.16% YoY), while the FY2025 annual figure was $515000.0, up 66.13% from the prior year.
- Tax Provisions was $190000.0 for Q1 2026 at Structure Therapeutics, up from $170000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $405000.0 in Q3 2023 to a low of -$326000.0 in Q4 2023.
- Historically, Tax Provisions has averaged $73764.7 across 5 years, with a median of $92000.0 in 2024.
- Biggest YoY gain for Tax Provisions was 454.79% in 2023; the steepest drop was 81.11% in 2023.
- A 5-year view of Tax Provisions shows it stood at -$180000.0 in 2022, then slumped by 81.11% to -$326000.0 in 2023, then soared by 141.72% to $136000.0 in 2024, then grew by 25.0% to $170000.0 in 2025, then increased by 11.76% to $190000.0 in 2026.
- The last three Tax Provisions figures came in at $190000.0 (Q1 2026), $170000.0 (Q4 2025), and $108000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Structure Therapeutics | 9.35 Bn | 9.35 Bn | - | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | 136,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | -326,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -180,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 60,000.00 |